BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND LPP, Q93052, 4026, ENSG00000145012
11 results:

  • 1. Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles.
    Hirano T; Arai E; Fujimoto M; Nakayama Y; Tian Y; Ito N; Makabe T; Yamagami W; Susumu N; Aoki D; Kanai Y
    J Gynecol Oncol; 2022 Nov; 33(6):e74. PubMed ID: 36047377
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Therapeutic Implications of Germline Testing in Patients With Advanced cancers.
    Stadler ZK; Maio A; Chakravarty D; Kemel Y; Sheehan M; Salo-Mullen E; Tkachuk K; Fong CJ; Nguyen B; Erakky A; Cadoo K; Liu Y; Carlo MI; Latham A; Zhang H; Kundra R; Smith S; Galle J; Aghajanian C; Abu-Rustum N; Varghese A; O'Reilly EM; Morris M; Abida W; Walsh M; Drilon A; Jayakumaran G; Zehir A; Ladanyi M; Ceyhan-Birsoy O; Solit DB; Schultz N; Berger MF; Mandelker D; Diaz LA; Offit K; Robson ME
    J Clin Oncol; 2021 Aug; 39(24):2698-2709. PubMed ID: 34133209
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome.
    Hinshaw JC; Zhao LP; Brimm JE; Payne TH; Hisama FM
    J Genet Couns; 2021 Dec; 30(6):1591-1597. PubMed ID: 33881185
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy.
    Arjona-Sánchez A; Cortés-Guiral D; Duran-Martínez M; Villarejo-Campos P; Sánchez-Hidalgo JM; Casado-Adam A; Rodriguez-Ortiz L; Romero-Ruiz A; Rufian-Andujar B; Espinosa-Redondo E; Valenzuela-Molina F; Rufián-Peña S; Briceño-Delgado J
    Tech Coloproctol; 2020 Oct; 24(10):1083-1088. PubMed ID: 32725353
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.
    Chen B; Zhang G; Li X; Ren C; Wang Y; Li K; Mok H; Cao L; Wen L; Jia M; Li C; Guo L; Wei G; Lin J; Li Y; Zhang Y; Han-Zhang H; Liu J; Lizaso A; Liao N
    Aging (Albany NY); 2020 Feb; 12(4):3140-3155. PubMed ID: 32091409
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Distinct Clinical Courses of Epithelial ovarian cancer with Mutations in
    Eoh KJ; Park HS; Park JS; Lee ST; Han JW; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    Anticancer Res; 2018 Dec; 38(12):6947-6953. PubMed ID: 30504414
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer-associated fibroblasts regulate endothelial adhesion protein lpp to promote ovarian cancer chemoresistance.
    Leung CS; Yeung TL; Yip KP; Wong KK; Ho SY; Mangala LS; Sood AK; Lopez-Berestein G; Sheng J; Wong ST; Birrer MJ; Mok SC
    J Clin Invest; 2018 Feb; 128(2):589-606. PubMed ID: 29251630
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].
    Tanyi J; Rigó J
    Orv Hetil; 2009 Jun; 150(24):1109-18. PubMed ID: 19739275
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
    Tanyi JL; Hasegawa Y; Lapushin R; Morris AJ; Wolf JK; Berchuck A; Lu K; Smith DI; Kalli K; Hartmann LC; McCune K; Fishman D; Broaddus R; Cheng KW; Atkinson EN; Yamal JM; Bast RC; Felix EA; Newman RA; Mills GB
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3534-45. PubMed ID: 14506139
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
    Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
    Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.